Description
PHARMACEUTICALS
First action · last action
2016-08-19 · 2016-08-24
Transactions
2
First transaction's obligation
$17,955
Base + all options value (sum of deltas)
$17,955
Extent competed
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Other than full & open authority
—
Set-aside
SERVICE DISABLED VETERAN OWNED SMALL BUSINESS SET-ASIDE
Offers received
8
SDVOSB flag on record
Yes (self-representation)
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-08-19+$17,955= $17,955
- Mod P000012016-08-24+$0= $17,955
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-08-19 | +$17,955 | $17,955 | PHARMACEUTICALS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2016-08-24 | +$0 | $17,955 | PHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI U1GZZRBWMK95)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA77016P1667 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2016 |
| VA76013P0342 | 255-NETWORK CONTRACT OFFICE 15 · 6505 · DRUGS AND BIOLOGICALS | $9,693 | FY2013 |
| VA76013P0336 | 255-NETWORK CONTRACT OFFICE 15 · 6505 · DRUGS AND BIOLOGICALS | $4,058 | FY2013 |
| VA76013P0296 | 255-NETWORK CONTRACT OFFICE 15 · 6505 · DRUGS AND BIOLOGICALS | $722 | FY2013 |
| VA76013P0285 | 255-NETWORK CONTRACT OFFICE 15 · 6505 · DRUGS AND BIOLOGICALS | $2,342 | FY2013 |
| VA76013P0309 | 255-NETWORK CONTRACT OFFICE 15 · 6505 · DRUGS AND BIOLOGICALS | $2,321 | FY2013 |
Other recipients under 6515 from NATIONAL CMOP OFFICE (36C770) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C77026N0048 | MERZ PHARMACEUTICALS, LLC | NATIONAL CMOP OFFICE (36C770) | $236,612 | FY2026 |
| 36C77026K0041 | ALPHAPOINTE | NATIONAL CMOP OFFICE (36C770) | $993,585 | FY2026 |
| 36C77026P0104 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $17,964 | FY2026 |
| 36C77026F0045 | ATOS MEDICAL INC | NATIONAL CMOP OFFICE (36C770) | $513,331 | FY2026 |
| 36C77026K0040 | ALPHAPOINTE | NATIONAL CMOP OFFICE (36C770) | $1,505,645 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA77016P1514_3600_-NONE-_-NONE- · retrieved 2026-09-26.